- $273.39m
- $104.29m
- $91.63m
- 55
- 86
- 67
- 79
2019 September 30th | 2020 September 30th | 2021 September 30th | R2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 82.7 | 94.2 | 97.8 | 81.9 | 83.5 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 80.9 | 84.1 | 97.8 | 81.2 | 83.5 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 57.6 | 139 | 94.4 | 41 | 37 |
Provision for Income Taxes | |||||
Net Income After Taxes | 43.2 | 104 | 73.7 | 31.6 | 27.9 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 43.2 | 104 | 73.7 | 32.1 | 21.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 43.2 | 104 | 73.7 | 32.1 | 21.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.06 | 14 | 10.1 | 4.26 | 3.77 |
Dividends per Share | |||||
Special Dividends per Share |